Health Care·Health Care Equipment·$21.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.70 | N/A | +6.06% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.70 | N/A | +6.06% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook regarding earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing operational improvements and cost management strategies.
The earnings report shows that STERIS PLC exceeded expectations on EPS, which likely contributed to the stock's strong 8.47% increase. The lack of revenue data may raise questions among investors, but the positive EPS surprise indicates effective cost management and operational efficiency. Investors may view this as a sign of resilience in the company's financial performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013